Intellipharmaceutics International : Announces Third Quarter

TORONTO, ON / October 15, 2021 / Intellipharmaceutics International Inc. and , a pharmaceutical company specializing in the research, development and manufacture of novel and generic... | October 16, 2021

Related Keywords

Delaware , United States , Canada , Toronto , Ontario , Purdue Pharma , Isa Odidi , Company Oxycodone , Company Contact , Company The Common , United States District Court , Risk Management Advisory Committee , Nasdaq , Drug Products Advisory Committee , Tris Pharma Inc , Toronto Stock Exchange , Intellipharmaceutics International Inc , Company Aximris , Health Canada , Party Transactions , Intellipharmaceutics International , Tris Pharma , Common Share , Common Shares , United States Securities Act , Private Placement , Analgesic Drug Products Advisory Committee , Drug Safety , Advisory Committees , Point Of Divergence Drug Delivery System , Securities Act , Management Discussion , Intellipharmaceutics International Inc Stock Exchange , News , Information , Press Release , N , October , 021 , Intellipharmaceutics , Nternational , End , Harmaceutical , Company , Pecializing , The , Development , Manufacture , F , Novel , Nd Ipci Ca4581733090 ,